Brief: Vivesto Initiates Clinical Development Of Paccal Vet In Veterinary Oncology
March 20 (Reuters) - Vivesto AB VIVE.ST :
* VIVESTO INITIATES CLINICAL DEVELOPMENT OF PACCAL VET IN
VETERINARY ONCOLOGY
* TO INITIATE CLINICAL DEVELOPMENT OF VETERINARY ONCOLOGY
DRUG
CANDIDATE PACCAL VET (PACLITAXEL MICELLAR).
Source text for Eikon: ID:nMFN1HZXwX
Further company coverage: VIVE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO